OverviewChartNewsTraderScreen

BVT Knock-Out VRTX/  DE000VD064P5  /

Stuttgart
11/12/2024  1:48:51 PM Chg.+0.30 Bid2:15:08 PM Ask2:15:08 PM Underlying Strike price Expiration date Option type
12.29EUR +2.50% 12.32
Bid Size: 5,000		 -
Ask Size: -		 Vertex Pharmaceutica... 377.82 USD 12/31/2078 Call
GlobeNewswire 8/13 Entrada Therapeutics Reports Second Quarter 2024 Financial Results
GlobeNewswire 8/9 ProKidney Reports Business Updates and Second Quarter 2024 Financial Results
GlobeNewswire 8/7 Editas Medicine Announces Second Quarter 2024 Results and Business Updates
GlobeNewswire 8/5 Spero Therapeutics Announces Second Quarter 2024 Operating Results and Provides a Business Update
GlobeNewswire 8/5 CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2024 Financial Results
Newsfile Corp 7/17 Analysts Hunt for Undervalued Biotech Stocks
Newsfile Corp 7/11 Biopharma Stocks Transformative Innovation for the Future of Health
GlobeNewswire 7/9 Payscale Expands Data & Technology Resources, Powering Decision-Focused Compensation Management
GlobeNewswire 7/9 Attovia Therapeutics Announces Election of Mitchell Gold and Angie You to Board of Directors
GlobeNewswire 6/28 Verve Therapeutics Announces Appointment of Nia Tatsis, Ph.D., and Jodie Morrison to its Board of Di...
GlobeNewswire 6/10 Centessa Pharmaceuticals Strengthens Executive Leadership with Appointment of John Crowley CPA, as C...
GlobeNewswire 5/29 CRISPR Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire 5/23 CRISPR Therapeutics Strengthens Executive Leadership Team with Key Appointments
GlobeNewswire 5/15 Third Harmonic Bio Announces First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 5/9 CRISPR Therapeutics to Present at the Bank of America Securities Health Care Conference
GlobeNewswire 5/8 CRISPR Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
GlobeNewswire 5/8 CRISPR Therapeutics Highlights ASGCT Oral Presentation and Announces New Programs Utilizing In Vivo ...
GlobeNewswire 5/8 Editas Medicine Announces First Quarter 2024 Results and Business Updates
GlobeNewswire 5/7 Prelude Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 4/30 American Kidney Fund Encourages People to Be APOL1 Aware with First Annual APOL1-Mediated Kidney Dis...
GlobeNewswire 4/27 SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLC Investigates MODN, AIRC, INRD, ALPN
GlobeNewswire 4/25 American Kidney Fund Launches National Kidney Health Equity Media Campaign
GlobeNewswire 4/22 TAKE ACTION: The M&A Class Action Firm Launches Legal Inquiry for the Merger - ALPN, LABP, SWAV, FUS...
GlobeNewswire 4/22 CRISPR Therapeutics to Present Oral Presentation at the American Society of Gene & Cell Therapy (ASG...
GlobeNewswire 4/22 SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates INRD, AIRC, ELYM, ALPN